Quantcast

Concise Analysis on the International Pain Management Treatment Markets - KOAM TV 7

Concise Analysis on the International Pain Management Treatment Markets

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, February 5, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/f3g6bf/pain_management) has announced the addition of the "Concise Analysis on the International Pain Management Treatment Markets" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Pain management describes a particular set of drugs, analgesics, which are specifically used as therapeutics to control pain in the clinic. As pain affects 1.5 billion people worldwide, these drugs are one of the major segments of the central nervous system (CNS) therapies market. This TriMark Publications report focuses on the role of pain management drugs in clinical use and in drug development for acute pain, chronic pain, neuropathic path and nociceptive pain. The report discusses drug development and targeted therapeutics, as well as their use in clinical trials. New approaches meant to aid in development of drugs for therapeutic use are emphasized.

The study also analyzes almost all of the major, specialty and emerging companies known to be marketing, manufacturing or developing pain management treatment products in the U.S. and worldwide. Additionally, this review provides detailed tables, charts and figures with past and projected sales data for the U.S., Europe and other geographic regions. 


Key Topics Covered: 

1. Overview 

2. Introduction

3. Market Overview

4. Pipeline Analysis 

5. The Changing Competitive Landscape 

6. Market Outlook 

7. Company Profiles 


Companies Mentioned:

  • Abbott (AbbVie)
  • AcelRx
  • Acura Pharmaceuticals
  • Afferent Pharmaceuticals
  • Algiax Pharmaceuticals
  • Arcion Therapeutics
  • Astellas
  • BioDelivery Sciences International
  • Cara Therapeutics
  • Cephalon (Teva)
  • Convergence Pharmaceuticals
  • Cytogel Pharma
  • DURECT
  • Egalet a/s
  • Eli Lilly
  • Emerging Biotechs
  • Endo Pharmaceuticals
  • Grunenthal
  • Hospira
  • Johnson & Johnson
  • KemPharm
  • Mallinckrodt
  • NeurAxon
  • NeurogesX
  • Newron Pharmaceuticals
  • Novartis
  • Nuvo Research
  • Pacira Pharmaceuticals
  • Pain Specialty Companies
  • Pain Therapeutics
  • Pfizer
  • Purdue Pharma
  • QRx Pharma
  • Relevare Pharmaceuticals
  • Relmada Therapeutics
  • Spinifex Pharma
  • Xenon Pharma
  • Xenoport
  • Zalicus
  • Zogenix
  • iMed


For more information visit http://www.researchandmarkets.com/research/f3g6bf/pain_management

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

KOAM - Licensed to Pittsburg, Kansas
Send tips, ideas and press releases to: tips@koamtv.com
Send newsroom questions or comments to: comments@koamtv.com
Phone: (417) 624-0233 or (620) 231-0400
Web comments or questions: webmaster@koamtv.com
Newsroom Fax: (417) 624-3158

Powered by WorldNow All content © Copyright 2000 - 2014 WorldNow and KOAM. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.